FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Haelan 0.0125% ointment (Typharm Ltd) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Carbo-Dome 10% cream (Sandoz Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Carbo-Dome 10% cream (Sandoz Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nystan 100,000units/g ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 2% ointment (A A H Pharmaceuticals Ltd) 450 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 2% ointment (J M Loveridge Plc) 450 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 2% ointment (Thornton & Ross Ltd) 450 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 2% ointment (Unichem Plc) 450 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nerisone 0.1% cream (Meadow Laboratories) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nerisone Forte 0.3% oily cream (Meadow Laboratories) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dithrocream 2% cream (Dermal Laboratories Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dithrocream HP 1% cream (Dermal Laboratories Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Siopel cream (Centrapharm Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lidocaine 5% ointment (A A H Pharmaceuticals Ltd) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lidocaine 5% ointment (Unichem Plc) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Anthisan 2% cream (Aventis Pharma) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Anthisan 2% cream (Aventis Pharma) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Psorin ointment (L.P.C Medical) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Psorin ointment (L.P.C Medical) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Psorin ointment (L.P.C Medical) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar N ointment (GP Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Morhulin ointment (Thornton & Ross Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hioxyl 1.5% cream (Ferndale Pharmaceuticals Ltd) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hioxyl 1.5% cream (Ferndale Pharmaceuticals Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Meted shampoo (Alliance Pharmaceuticals Ltd) 120 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Warticon 0.15% cream (Stiefel Laboratories Ltd) 5 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Verrugon complete 50% ointment (William Ransom & Son Plc) 6 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zorac 0.1% gel (Allergan Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zorac 0.1% gel (Allergan Ltd) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mycota cream (Thornton & Ross Ltd) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 12% collodion (A A H Pharmaceuticals Ltd) 100 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 12% collodion (A A H Pharmaceuticals Ltd) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 12% collodion (J M Loveridge Plc) 100 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 12% collodion (J M Loveridge Plc) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Salicylic acid 12% collodion (Unichem Plc) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Solarcaine cream (Schering-Plough Ltd) 25 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    CX 1% powder (Adams Healthcare) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Psorin scalp gel (L.P.C Medical) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nerisone 0.1% ointment (Meadow Laboratories) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nerisone Forte 0.3% ointment (Meadow Laboratories) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Micanol 3% cream (GP Pharma) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Micanol 1% cream (GP Pharma) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Vesagex 1% cream (Co-Pharma Ltd) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Vesagex 1% cream (Co-Pharma Ltd) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Vesagex 1% cream (Co-Pharma Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Halciderm Topical 0.1% cream (Bristol-Myers Squibb Pharmaceuticals Limited) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ichthammol 10% ointment (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ichthammol 10% ointment (Thornton & Ross Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (Kent Pharma (UK) Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Brulidine 0.15% cream (Manx Pharma Ltd) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Pickles 0.15% antiseptic cream (William Ransom & Son Plc) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Solarcaine 0.5% gel (Schering-Plough Ltd) 135 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc and Salicylic acid paste (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc and Salicylic acid paste (Thornton & Ross Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc and Salicylic acid paste (Unichem Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Quinoderm 5 cream (Ferndale Pharmaceuticals Ltd) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nicam 4% gel (Dermal Laboratories Ltd) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Vagisil 2% medicated cream (Combe International Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Differin 0.1% cream (Galderma (UK) Ltd) 45 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Differin 0.1% gel (Galderma (UK) Ltd) 45 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elidel 1% cream (Viatris UK Healthcare Ltd) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elidel 1% cream (Viatris UK Healthcare Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Posalfilin ointment (Norgine Ltd) 10 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mycil ointment (Crookes Healthcare Ltd) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betadine 5% cream (SSL International Plc) 8 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Wartex 50% ointment (William Ransom & Son Plc) 6 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Tinaderm Plus 1% powder (Schering-Plough Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Scholl Athlete's Foot 1% powder (SSL International Plc) 75 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Tinaderm 1% cream (Organon Pharma (UK) Ltd) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Scholl Athlete's Foot 1% cream (SSL International Plc) 25 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc cream (A A H Pharmaceuticals Ltd) 400 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc cream (J M Loveridge Plc) 400 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc ointment (J M Loveridge Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc ointment (Unichem Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Simple ointment (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc compound paste (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc compound paste (Thornton & Ross Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc compound paste (Unichem Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (A A H Pharmaceuticals Ltd) 100 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (A A H Pharmaceuticals Ltd) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (J M Loveridge Plc) 100 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (J M Loveridge Plc) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (J M Loveridge Plc) 2 litre Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflavine 0.1% cream (Unichem Plc) 500 ml Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar N cream (GP Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc and Ichthammol cream (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zinc and Ichthammol cream (Unichem Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Approved Prescription Services) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Approved Prescription Services) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% ointment (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Approved Prescription Services) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Approved Prescription Services) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% ointment (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lidocaine 5% ointment (Approved Prescription Services) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrous wool fat (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrous wool fat (J M Loveridge Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Buffered cream (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 33 of 55 Next End


    This concept is not in any reference sets

    Back to Start